Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

In Memory of Dr. Herbert E. Nieburgs – Ex-Associate Editor of CCDT promotion: free to download

Volume:13   Issue: 8
Pp: 811-813

DOI: 10.2174/1568009611313080001

Protein Phosphatase 2A as a Potential Target for Treatment of Adult T Cell Leukemia

Volume:13   Issue: 8
Pp: 829-842
Naoki Mori, Chie Ishikawa, Jun-Nosuke Uchihara and Takeshi Yasumoto
DOI: 10.2174/156800961131300093

Signal Transduction in Human Cutaneous Melanoma and Target Drugs open access plus

Volume:13   Issue: 8
Pp: 843-866
Anatoly B. Uzdensky, Svetlana V. Demyanenko and Mikhail Y. Bibov
DOI: 10.2174/1568009611313080004

β-Catenin Knockdown in Liver Tumor Cells by a Cell Permeable Gamma Guanidine-based Peptide Nucleic Acid open access plus

Volume:13   Issue: 8
Pp: 867-878
Evan Delgado, Raman Bahal, Jing Yang, Jung M. Lee, Danith H Ly and Satdarshan P. S. Monga
DOI: 10.2174/15680096113139990081

Ipilimumab and Vemurafenib: Two Different Routes for Targeting Melanoma

Volume:13   Issue: 8
Pp: 879-894
Ana Burgeiro, Faustino Mollinedo and Paulo J. Oliveira
DOI: 10.2174/15680096113139990080

Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance

Volume:13   Issue: 8
Pp: 895-904
Caroline Hinton, Helma Antony, Saeed M. Hashimi, Alan Munn and Ming Q. Wei
DOI: 10.2174/156800961131300092